200 related articles for article (PubMed ID: 9987794)
21. Synthesis, antitubercular and anticancer activities of substituted furyl-quinazolin-3(4H)-ones.
Raghavendra NM; Thampi P; Gurubasavarajaswamy PM; Sriram D
Arch Pharm (Weinheim); 2007 Dec; 340(12):635-41. PubMed ID: 17994604
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, transformations and tuberculostatic activity of 1-(N-aroylthiocarbamoyl)imidiazolidine-2-thiones.
Saczewski F
Acta Pol Pharm; 1993; 50(4-5):341-4. PubMed ID: 8036919
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
24. Anti-tuberculosis activity of some N-pentopyranosylamines.
Moczulska A
Acta Pol Pharm; 2004; 61(4):259-62. PubMed ID: 15575591
[TBL] [Abstract][Full Text] [Related]
25. Some reactions of 2-cyanomethyl-3-methyl-3H-imidazo[4,5-b]pyridine with isothiocyanates. Antituberculotic activity of the obtained compounds.
Bukowski L
Pharmazie; 2001 Jan; 56(1):23-7. PubMed ID: 11210662
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
Puratchikody A; Natarajan R; Jayapal M; Doble M
Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
[TBL] [Abstract][Full Text] [Related]
27. Effect of substituents on diarylmethanes for antitubercular activity.
Panda G; Parai MK; Das SK; Shagufta ; Sinha M; Chaturvedi V; Srivastava AK; Manju YS; Gaikwad AN; Sinha S
Eur J Med Chem; 2007 Mar; 42(3):410-9. PubMed ID: 17112639
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and screening of (E)-1-(β-D-galactopyranosyl)-4-(aryl)but-3-ene-2-one against Mycobacterium tuberculosis.
Mugunthan G; Ramakrishna K; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
Bioorg Med Chem Lett; 2011 Jul; 21(13):3947-50. PubMed ID: 21641797
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents.
Sinha N; Jain S; Tilekar A; Upadhayaya RS; Kishore N; Jana GH; Arora SK
Bioorg Med Chem Lett; 2005 Mar; 15(6):1573-6. PubMed ID: 15745799
[TBL] [Abstract][Full Text] [Related]
30. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antituberculosis activity of new hydrazide derivatives.
Kaplancikli ZA; Turan-Zitouni G; Ozdemir A; Teulade JC
Arch Pharm (Weinheim); 2008 Nov; 341(11):721-4. PubMed ID: 18720343
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antituberculosis activity of some N-pyridyl-N'-thiazolylhydrazine derivatives.
Turan-Zitouni G; Kaplancikli ZA; Ozdemir A
Eur J Med Chem; 2010 May; 45(5):2085-8. PubMed ID: 20149489
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents.
Tangallapally RP; Yendapally R; Lee RE; Hevener K; Jones VC; Lenaerts AJ; McNeil MR; Wang Y; Franzblau S; Lee RE
J Med Chem; 2004 Oct; 47(21):5276-83. PubMed ID: 15456272
[TBL] [Abstract][Full Text] [Related]
34. Quinolizidine derivatives with antitubercular activity.
Vazzana I; Novelli F; Sparatore F; Sparatore A; Fadda G; Manca C
Farmaco; 1994 Feb; 49(2):105-10. PubMed ID: 8003177
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
[No Abstract] [Full Text] [Related]
36. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
[TBL] [Abstract][Full Text] [Related]
37. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
Kuang T; Jin G; Song P; Li W; Wang Z
Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.
Turan-Zitouni G; Ozdemir A; Kaplancikli ZA; Benkli K; Chevallet P; Akalin G
Eur J Med Chem; 2008 May; 43(5):981-5. PubMed ID: 17719146
[TBL] [Abstract][Full Text] [Related]
39. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
40. Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR.
Vicente E; Duchowicz PR; Ortiz Edel V; Monge A; Castro EA
Chem Biol Drug Des; 2010 Jul; 76(1):59-69. PubMed ID: 20492446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]